argenx stock after-hours at EUR 810.80: minus 0.69 percent versus prior close
Published on 10/05/2026 at 17:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
argenx stock was at EUR 810.80 in after-hours trading at Lang & Schwarz at 5:52 p.m. CEST on October 5, 2026. The price was down EUR 5.60, or 0.69 percent, versus the prior close of EUR 816.40.
After-hours trading on October 5
The Lang & Schwarz bid was EUR 809.60 and the ask was EUR 812.00. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of argenx stock.
argenx presented new neuromuscular data
In a September 29, 2026 release, GlobeNewswire reported that argenx SE presented data from its portfolio and pipeline at the 2026 AANEM Annual Meeting and MGFA Scientific Session, held September 29 through October 2 in Orlando, Florida. The release said the data covered VYVGART in myasthenia gravis and chronic inflammatory demyelinating polyneuropathy, as well as empasiprubart and adimanebart.
The company said a real-world analysis of more than 1,100 U.S. patients with myasthenia gravis showed improvements in MG-ADL scores, steroid burden and exacerbation rates among VYVGART-treated patients. It also reported that 87 percent of patients in a Phase 4 switch study remained on VYVGART Hytrulo through 12 weeks after transitioning from IVIg.
